A. Baki Agbas in Mitochondrial Dysfunction 490 Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients
A. Baki Agbas in Mitochondrial Dysfunction 500 Mitochondrial dysfunction in amyotrophic lateral sclerosis-a valid pharmacological target
A. Baki Agbas in Mitochondrial Dysfunction 477 Misfolded Mutant SOD1 Directly Inhibits VDAC1 conductance in a mouse model of inherited ALS
A. Baki Agbas in Mitochondrial Dysfunction 463 Is Amyotrophic Lateral Sclerosis a mitochondrial channelopathy
A. Baki Agbas in Mitochondrial Dysfunction 480 Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS
A. Baki Agbas in Mitochondrial Dysfunction 470 Toxicity of Familial ALS-Linked SOD1 Mutants from selective recruitment to spinal mitochondria
A. Baki Agbas in Mitochondrial Dysfunction 484 Oxidative stress and mitochondrial damage in the pathogenesis of ALS-New perspectives
A. Baki Agbas in Mitochondrial Dysfunction 4781 The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity
A. Baki Agbas in Mitochondrial Dysfunction 5081 New therapeutic avenue for ALS_ Avoiding a fatal encounter of TDP-43 at the mitochondria
